Companies / Serina Therapeutics, Inc.

Serina Therapeutics, Inc.

NYSE: SERCIK 1708599HUNTSVILLE, AL

Financials · FY2025

Revenue$130.0K
Net income$-19.21M
Total debt$11.15M
Cash$23.02M
Diluted EPS$-1.91
Shares outstanding15.0M

Ownership

15.0M shares outstanding · as of May 10, 2026
57.2%Insiders
Ownership
Insiders57.24%8,584,582
Institutions3.02%453,018
Public float39.74%5,959,905

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 7

View all →
Insider% of sharesShares
57.11%8,564,382
Ledger Steven aCEOChief Executive Officer · Director
0.07%10,100
0.07%10,100
Moreadith RandallChief Scientific Officer
0.00%0
Curhan Gregory SFormerChief Financial Officer
Gill SimbaDirector
Tenjarla SriniSVP, CMC & Formulation

Institutional holders 23

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 17, 2026Bailey Gregory
Director
OtherCommon Stock$15.00M+6.7M
+351.30%
8,564,382
57.11% of shares
low
Jun 17, 2026Bailey Gregory
Director
OtherCommon Stock$3.98M+1.8M
+1398.30%
1,897,445
12.65% of shares
low
Mar 31, 2026Bailey Gregory
Director
GrantCommon Stock$115.8K+60K
+88.73%
126,910
0.85% of shares
low
Mar 19, 2026Moreadith Randall
Executive
SellCommon Stock$97.5K-39K
-100.00%
0
0.00% of shares
low
Jan 8, 2026Moreadith Randall
Executive
SellCommon Stock$35.0K-13K
-100.00%
0
0.00% of shares
low
Jan 28, 2026Moreadith Randall
Executive
SellCommon Stock$23.2K-7K
-100.00%
0
0.00% of shares
low
Feb 2, 2026Moreadith Randall
Executive
SellCommon Stock$19.7K-7K
-100.00%
0
0.00% of shares
low
May 26, 2026Ledger Steven a
CEO
GrantCommon Stock$19.5K+10K
10,100
0.07% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
SERCommon StockEquity81751A108BBG00HCXQ7B0